Buy Lupin Ltd. target Rs 1470.0 : Sumeet Bagadia

Sumeet Bagadia of Choice Equity Broking Private Ltd has a buy call on Lupin Ltd. with a target price of Rs 1470.The current market price of Lupin Ltd. is Rs 1423.75 Time period given by analyst is Intra Day when Lupin Ltd. price can reach defined target. Sumeet Bagadia recommended to keep stoploss at Rs 1400..

Lupin Ltd., incorporated in the year 1983, is a largecap company with a market cap of ₹ 64476.15 Cr.) operating in Pharmaceuticals and health care sector.

Lupin Ltd. key Products/Revenue Segments include Tablets which contributed ₹ 6391.82 Cr to Sales Value (56.14 % of Total Sales), Capsules which contributed ₹ 1500.79 Cr to Sales Value (13.18 % of Total Sales), Bulk Drugs (Intermediates) which contributed ₹ 1205.07 Cr to Sales Value (10.58 % of Total Sales), Liquids (Formulations) which contributed ₹ 693.58 Cr to Sales Value (6.09 % of Total Sales), Injectible Vials which contributed ₹ 605.95 Cr to Sales Value (5.32 % of Total Sales), Export Incentives which contributed ₹ 349.52 Cr to Sales Value (3.07 % of Total Sales), Other Services which contributed ₹ 259.91 Cr to Sales Value (2.28 % of Total Sales), Other Operating Revenue which contributed ₹ 120.54 Cr to Sales Value (1.05 % of Total Sales), Inhalers which contributed ₹ 79.92 Cr to Sales Value (0.70 % of Total Sales), Others which contributed ₹ 72.79 Cr to Sales Value (0.63 % of Total Sales), Creams & Powders which contributed ₹ 65.53 Cr to Sales Value (0.57 % of Total Sales) and Liquids (Injectables) which contributed ₹ 38.62 Cr to Sales Value (0.33 % of Total Sales)for the year ending 31-Mar-2016.

For the quarter ended 31-12-2016, the company has reported a Consolidated sales of ₹ 4404.94 Cr., up 4.60% from last quarter Sales of ₹ 4211.18 Cr. and up 31.48% from last year same quarter Sales of ₹ 3350.33 Cr. Company has reported net profit after tax of ₹ 633.09 Cr. in latest quarter. The company’s CEO is Mr.Nilesh Gupta. It's Board of Directors include Mr.R V Satam, Dr.Cyrus Karkaria, Dr.Desh Bandhu Gupta, Dr.Fabrice Egros, Dr.K U Mada, Dr.Kamal K Sharma, Dr.Kurt Nielsen, Dr.Rajender Kamboj, Dr.Sofia Mumtaz, Dr.Thierry Volle, Dr.Vijay Kelkar, Mr.Alok Ghosh, Mr.Debabrata Chakravorty, Mr.Dileep C Choksi, Mr.Divakar Kaza, Mr.Jean-Luc Belingard, Mr.Martin Mercer, Mr.Naresh Gupta, Mr.Nilesh Gupta, Mr.Noriaki Tsunoda, Mr.Paul McGarty, Mr.Pradeep Bhagwat, Mr.R A Shah, Mr.R V Satam, Mr.Rajeev Sibal, Mr.Ramesh Swaminathan, Mr.Ramesh Swaminathan, Mr.Richard Zahn, Mr.Shakti Chakraborty, Mr.Shamsher Gorawara, Mr.Sunil Makharia, Mr.Vinita Gupta, Mrs.Manju D Gupta. Company has its registered office at 159, C.S.T Road,, Kalina,, Santacruz (E), Mumbai, 400098, Maharashtra. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2017, the company has a total of 451,576,869 shares outstanding.